N-acetylcysteine - A Convenient Rationale for COVID-19

--Amatore, D., Celestino, I., Brundu, S., Galluzzi, L., Coluccio, P., Checconi, P., . . . Nencioni, L. (2019). Glutathione increase by the n-butanoyl glutathione derivative (GSH-C4) inhibits viral replication and induces a predominant Th1 immune profile in old mice infected with influenza virus. FASEB BioAdvances, 1(5), 296-305. doi:10.1096/fba.2018-00066

--de Alencar JCG,Moreira, CdL,Müller AD...Souza HP(2020)-Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by COVID-19,Clinical Infectious Diseases, , ciaa1443, https://doi.org/10.1093/cid/ciaa1443.

b—Barbaro RP et al Lancet Volume 396, ISSUE 10257,P1071-1078 doi.org/10.1016/S0140-6736(20)32008-0

a--Bazhanov, N., Ansar, M., Ivanciuc, T., Garofalo, R. P., & Casola, A. (2017). Hydrogen Sulfide: A Novel Player in Airway Development, Pathophysiology of Respiratory Diseases, and Antiviral Defenses. Am J Respir Cell Mol Biol, 57(4), 403-410. doi:10.1165/rcmb.2017-0114TR

b--Bazhanov, N., Escaffre, O., Freiberg, A. N., Garofalo, R. P., & Casola, A. (2017). Broad-Range Antiviral Activity of Hydrogen Sulfide Against Highly Pathogenic RNA Viruses. Scientific Reports, 7(1), 41029. doi:10.1038/srep41029

c-- Blanco-Melo, D et al (2020) Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 ;Cell – 181/5, - 1036-1045,e9.

--Boulware DR, Pullen MF, Bangdiwala AS, et al. ( 2020)A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2016638.

--Castelblanco, M., Lugrin, J., Ehirchiou, D., Nasi, S., Ishii, I., So, A., Martinon, F., & Busso, N. (2018). Hydrogen sulfide inhibits NLRP3 inflammasome activation and reduces cytokine production both in vitro and in a mouse model of inflammation. The Journal of biological chemistry, 293(7), 2546–2557. https://doi.org/10.1074/jbc.M117.806869

--Cerda, M. M., & Pluth, M. D. (2018). S Marks the Spot: Linking the Antioxidant Activity of N-Acetyl Cysteine to H?S and Sulfane Sulfur Species. Cell Chem Biol, 25(4), 353-355. doi:10.1016/j.chembiol.2018.04.001

b--Chen YH, Yao WZ, Geng B, Ding YL, Lu M, Zhao MW, Tang CS. Endogenous hydrogen sulfide in patients with COPD. Chest. 2005 Nov;128(5):3205-11. doi: 10.1378/chest.128.5.3205. PMID: 16304263.

--Citi, V, Martelli, A, Brancaleone, V, et al. Anti?inflammatory and antiviral roles of hydrogen sulfide: Rationale for considering H?S donors in COVID?19 therapy.Br J Pharmacol. 2020;1–doi10.1111/bph.15230

--Costa LS, Outlioua A, Anginot A, Akarid K, Arnoult D. RNA viruses promote activation of the NLRP3 inflammasome through cytopathogenic effect-induced potassium efflux. Cell Death Dis. (2019) 10:346. 10.1038/s41419-019-1579-0

b--Dattilo, M. The role of host defences in Covid 19 and treatments thereof. Mol Med 26, 90 (2020). https://doi.org/10.1186/s10020-020-00216-9

--Dautrebande, L. (1948). Arch Int Pharmacodyn Ther, 76(1), 109-116. https://www.ncbi.nlm.nih.gov/pubmed/18910204. cited in Pharmaceutisch Weekblad 1986;121,652 https://en.calameo.com/read/0032482285c12c79411eb

--De Flora, S., Grassi, C., & Carati, L. (1997). Attenuation of influenza-like symptomatology and improvement of cellmediated immunity with long-term N-acetylcysteine treatment. European Respiratory Journal, 10(7), 1535-1541.Retrieved from https://erj.ersjournals.com/content/erj/10/7/1535.full.pdf

b--De Flora, S, Balansky, R, La Maestra, S.(2020 ) Rationale for the use of N-acetylcysteine in both prevention and adjuvant therapy of COVID-19. The FASEB Journal.; 34:13185-13193. doi/10.1096/fj.202001807

--de Quay, B., Malinverni, R., & Lauterburg, B. H. (1992). Glutathione depletion in HIV-infected patients: role of cysteine deficiency and effect of oral N-acetylcysteine. Aids, 6(8), 815-819.

--De Rosa, S. C., Zaretsky, M. D., Dubs, J. G., Roederer, M., Anderson, M., Green, A., . . . Herzenberg, L. A. (2000). Nacetylcysteine replenishes glutathione in HIV infection. European Journal of Clinical Investigation, 30(10), 915-929. doi:10.1046/j.1365-2362.2000.00736.x

--DiNicolantonio, J. J., OKeefe, J. H., & McCarty, M. F. (2017). Boosting endogenous production of vasoprotective hydrogen sulfide via supplementation with taurine and N-acetylcysteine: a novel way to promote cardiovascular health. Open Heart, 4(1), e000600. doi:10.1136/openhrt-2017-000600

--Dröge, W. (1993). Cysteine and glutathione deficiency in AIDS patients: a rationale for the treatment with N-acetylcysteine. Pharmacology, 46(2), 61-65. doi:10.1159/000139029

b--Dröge W.(2005). Oxidative stress and ageing: Philos Trans R Soc Lond B Biol Sci 2005;360–2355–72.

c-Evgen'ev, M. B., & Frenkel, A. (2020). Possible application of H?S-producing compounds in therapy of coronavirus (COVID-19) infection and pneumonia. Cell stress & chaperones, 25(5), 713–715. https://doi.org/10.1007/s12192-020-01120-1

--Ezerina, D., Takano, Y., Hanaoka, K., Urano, Y., & Dick, T. P. (2018). N-Acetyl Cysteine Functions as a Fast-Acting Antioxidant by Triggering Intracellular H?S and Sulfane Sulfur Production. Cell Chem Biol, 25(4), 447-459 e444. doi:10.1016/j.chembiol.2018.01.011

--Fedson, D. S. (2016). Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola. Annals of translational medicine, 4(21), 421-421. doi:10.21037/atm.2016.11.03

--Gao, Y., Yan, L., Huang, Y., Liu, F., Zhao, Y., Cao, L., Wang, T., Sun, Q., Ming, Z., Zhang, L., Ge, J., Zheng, L., Zhang, Y., Wang, H.,Zhu, Y., Zhu, C., Hu, T., Hua, T., Zhang, B., Yang, X., Li, J., Yang, H., Liu, Z., Xu, W., Guddat, L.W., Wang, Q., Lou, Z.,Rao, Z., (2020). Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science..779–782.doi:10.1126/science.abb7498

--Garigliany, M. M., & Desmecht, D. J.(2011). N-acetylcysteine lacks universal inhibitory activity against influenza A viruses.Journal of negative results in biomedicine,10,5.https://doi.org/10.1186/1477-5751-10-5

--Gattinoni, L., Chiumello, D., & Rossi, S. (2020). COVID-19 pneumonia: ARDS or not? Critical Care, 24(1).doi:10.1186/s13054-020-02880-z

--van Goor, H., van den Born, J. C., Hillebrands, J-L., & Joles, J. A. (2016). Hydrogen sulfide in hypertension. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 25(2), 107-113.

doi: 10.1097/MNH.0000000000000206

--Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., Van Goor, H. (2004). Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. The Journal of Pathology, 203(2), 631-637. doi:10.1002/path.1570

—van Hezik, E,J, (2020) - Adapted Treatment Plan Step by Step in COVID-19 - version nov 2020 https://www.researchgate.net/publication/345982081

--Horowitz,RI., Phyllis R. Freeman,Ph., James Bruzzese.J.(2020). Efficacy of glutathione therapy in relieving dyspnea associated with COVID-19 pneumonia: report of 2 cases. Respir Med Case Rep. ; 30: 101063.doi:10.1016/j.rmcr.2020.101063

b--Hortin, G. L., Landt, M., & Powderly, W. G. (1994). Changes in plasma amino acid concentrations in response to HIV-1 infection. Clin Chem, 40(5), 785-789.

--Ibrahim, H., Perl, A., Smith, D., Lewis, T., Kon, Z., Goldenberg, R., Yarta, K., Staniloae, C., & Williams, M. (2020). Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine. Clinical immunology (Orlando, Fla.), 219, 108544. Advance online publication. https://doi.org/10.1016/j.clim.2020.108544

--Ivanciuc, T., Sbrana, E., Ansar, M., Bazhanov, N., Szabo, C., Casola, A.,Garofalo, R. P. (2016). Hydrogen Sulfide Is an Antiviral and Antiinflammatory Endogenous Gasotransmitter in the Airways. Role in Respiratory Syncytial Virus Infection. American Journal ofRespiratory Cell and Molecular Biology, 55(5), 684-696. doi:10.1165/rcmb.2015-0385OC

a--Jain SK, Bull R, Rains JL, et al. Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation?. Antioxid Redox Signal. 2010;12(11):1333-1337. doi:10.1089/ars.2009.2956

b--Jain M, Chandel NS.(2013) Rethinking antioxidants in the intensive care unit. Am J Respir Crit Care Med.2013;188(11):1283-1285.doi:10.1164/rccm.201307-1380CP

--Korber, B, Fischer, W., Gnanakaran, S, et al; doi: https://doi.org/10.1016/j.cell.2020.06.043

--Keller MJ,, Kitsis EA ,Arora S,( 2020) Effect of Systemic Glucocorticoids on Mortality or Mechanical Ventilation in Patients With COVID-19. J. Hosp. Med 2020;8;489-493. doi:10.12788/jhm.3497

--Kikkert, M. (2020). Innate Immune Evasion by Human Respiratory RNA Viruses. J Innate Immun, 12(1), 4-20. doi:10.1159/000503030

--Kimura H. (2015). Signaling molecules: hydrogen sulfide and polysulfide. Antioxidants & redox signaling, 22(5), 362–376.https://doi.org/10.1089/ars.2014.5869

--Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D. A. M. P. J., Kant, K. M., . . . Endeman, H. (2020).Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis Research. doi:https://doi.org/10.1016/j.thromres.2020.04.013

--Kumar, A., & Biswas, U. (2012). Further Research needed to understand the role of H?S as a biological mediator and therapeutic potential. Journal of Biomedical Sciences, 1, 1 to 2. doi:10.3823/1000

--Lai, A.L., Millet, J.K., Daniel, S., Freed, J.H., Whittaker, G.R., 2017. The SARS-CoV Fusion Peptide Forms an Extended Bipartite Fusion Platform that Perturbs Membrane Order in a Calcium-Dependent Manner. Journal of Molecular Biology..doi:10.1016/j.jmb.2017.10.017

--Lai, K. Y. (2010). High-Dose N-Acetylcysteine Therapy for Novel H1N1 Influenza Pneumonia. Annals of Internal Medicine, 152(10),687. doi:10.7326/0003-4819-152-10-201005180-00017

--Li, H., Ma, Y., Escaffre, O., Ivanciuc, T., Komaravelli, N., Kelley, J. P., . . . Casola, A. (2015). Role of Hydrogen Sulfide in Paramyxovirus Infections. Journal of Virology, 89(10), 5557-5568. doi:10.1128/jvi.00264-15.

b--Li H, Mani S, Wu L, et al. (2017).The interaction of estrogen and CSE/H?S pathway in the development of atherosclerosis. Am J Physiol Heart Circ Physiol 2017;312:H406–H414

-Lin, Y., Zeng, H., Gao, L., Gu, T., Wang, C., & Zhang, H. (2017). Hydrogen Sulfide Attenuates Atherosclerosis in a Partially Ligated Carotid Artery Mouse model via Regulating Angiotensin Converting Enzyme 2 Expression. Frontiers in Physiology, 8(782).doi:10.3389/fphys.2017.00782

--Lu, X., Ma, Y., He, J., Li, Y., Zhu, H., & Yu, X. (2019). N-acetylcysteine for adults with acute respiratory distress syndrome: A metaanalysis of randomized controlled trials. Hong Kong Journal of Emergency Medicine, 26(5), 288-298. doi:10.1177/1024907918794559

--Madu, I. G., Belouzard, S., & Whittaker, G. R. (2009). SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion. Virology, 393(2), 265-271. doi:10.1016/j.virol.2009.07.038

--Malik, Y. S., & Goyal, S. M. (2006). Virucidal efficacy of sodium bicarbonate on a food contact surface against feline calicivirus, a norovirus surrogate. International journal of food microbiology, 109(1-2), 160-163. doi:10.1016/j.ijfoodmicro.2005.08.033

--Marutani, E., Ichinose, F. Emerging pharmacological tools to control hydrogen sulfide signaling in critical illness. ICMx 8, 5 (2020).https://doi.org/10.1186/s40635-020-0296-4

b--Mason RJ (2020)-Pathogenesis of COVID-19 from a cell biology perspective.Eur Respir J,55/4 DOi - 10.1183/13993003.00607-2020

--Mehra MR,Desai SS,Ruschitzka F, et al.(2020). RETRACTION-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020; 395: 1820.

--Mehra MR, Desai SS, KuyS, et al (2020). Retraction: cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med. 2020. doi:10.1056/NEJMc2021225.

b--Miller, T. W., Wang, E. A., Gould, S.,et al (2012). Hydrogen sulfide is an endogenous potentiator of T cell activation.The Journal of biological chemistry, 287(6), 4211–21. doi10.1074/jbc.M111.307819

--Millet, J. K., & Whittaker, G. R. (2018). Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. Virology, 517, 3-8. doi:10.1016/j.virol.2017.12.015

--Moynihan R et al .(2020)- Commercial influence and covid-19 BMJ ;369 :m2456

--Olson, K. R. (2020). Reactive oxygen species or reactive sulfur species: why we should consider the latter. The Journal of Experimental Biology, 223(4), jeb196352. doi:10.1242/jeb.196352

--Otu, A., Langridge, P., & Denning, D. W. (2018). Nebulised N-Acetylcysteine for Unresponsive Bronchial Obstruction in Allergic Brochopulmonary Aspergillosis: A Case Series and Review of the Literature. J Fungi (Basel), 4(4). doi:10.3390/jof4040117

--Ou, X., Zheng, W., Shan, Y., Mu, Z., Dominguez, S. R., Holmes, K. V., & Qian, Z. (2016). Identification of the Fusion Peptide Containing Region in Betacoronavirus Spike Glycoproteins. J Virol, 90(12), 5586-5600. doi:10.1128/jvi.00015-16

--Palamara, A. T., Perno, C.-F., Ciriolo, M. R., Dini, L., Balestra, E., D'Agostini, C., . . . Garaci, E. (1995). Evidence for antiviral activity of glutathione: in vitro inhibition of herpes simplex virus type 1 replication. Antiviral Research, 27(3), 237-253.doi:https://doi.org/10.1016/0166-3542(95)00008-A

--Poe F., Corn J. (2020) N-Acetylcysteine: A potential therapeutic agent for SARS-CoV-2. Medical Hypotheses,143,109862 ,doi.org/10.1016/j.mehy.2020.109862

--Puyo C, Kreig D, Saddi V et al. (2020) Case Report: Use of hydroxychloroquine and N-acetylcysteine for treatment of a COVID-19 positive patient F1000Research 2020, 9:491 doi:10.12688/f1000research.23995.1) [version 1; peer review:1 not approved].

--Renieris G et al.(2020) --Serum Hydrogen Sulfide and outcome association in pneumonia by the Sars-CoV-2 Coronavirus. Shock Injury,Inflammation and Sepsis,May 18,2020 doi:10.1097/shk.0000000000001562 Publ ahead of print

--Rose, P., Moore, P. K., & Zhu, Y. Z. (2017). H?S biosynthesis and catabolism: new insights from molecular studies. Cellular and Molecular Life Sciences, 74(8), 1391-1412. doi:10.1007/s00018-016-2406-8

--Sekhar RV, Patel SG, Guthikonda AP, et al. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr 2011;94–847–53

--Siddiqi, H. K., & Mehra, M. R. (2020). COVID-19 Illness in Native and Immunosuppressed States: A Clinical-Therapeutic Staging Proposal. The Journal of Heart and Lung Transplantation. doi:10.1016/j.healun.2020.03.012

--Stipanuk MH, Ueki I, Dominy JE Jr, Simmons CR, Hirschberger LL. Cysteine dioxygenase: a robust system for regulation of cellular cysteine levels. Amino Acids. 2009;37(1):55-63. doi:10.1007/s00726-008-0202-y

--Sun, Q., Wang, B., Li, Y., Sun, F., Li, P., Xia, W., . . . Zhu, Z. (2016). Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study. Hypertension, 67(3), 541-549.doi:10.1161/HYPERTENSIONAHA.115.06624

--Szabo, C. (2018). A timeline of hydrogen sulfide (H?S) research: From environmental toxin to biological mediator. BiochemPharmacol, 149, 5-19. doi:10.1016/j.bcp.2017.09.010

--Thomas T, Stefanoni D, Reisz JA, et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. 2020;5(14):e140327. doi:10.1172/jci.insight.140327

a--Vardhana SA, Wolchok JD (2020); The many faces of the anti-COVID immune response. J Exp Med 1 ; 217: e20200678. doi: https://doi.org/10.1084/jem.20200678

b--Wallace, J., & Wang, R. (2015). Hydrogen sulfide-based therapeutics: Exploiting a unique but ubiquitous gasotransmitter. Nature reviews. Drug discovery, 14(5), 329-345 doi:10.1038/nrd4433

--Wang, B., Yee Aw, T., & Stokes, K. Y. (2018). N-acetylcysteine attenuates systemic platelet activation and cerebral vessel thrombosis in diabetes. Redox Biology, 14, 218-228. doi:10.1016/j.redox.2017.09.005

--Wang, R. (2002). Two's company, three's a crowd: can H?S be the third endogenous gaseous transmitter? The FASEB Journal,16(13), 1792-1798. doi:10.1096/fj.02-0211hyp

b--Whiteman M, Gooding KM, Whatmore JL, et al Adiposity is a major determinant of plasma levels of the novel vasodilator hydrogen sulphide. Diabetologia, 2010; DOI: 10.1007/s00125-010-1761-5 .

--Yadav PK, Vitvitsky V, Carballal S, Seravalli J, Banerjee R. (2020)Thioredoxin regulates human mercaptopyruvate sulfurtransferase at physiologically-relevant concentrations. J Biol Chem.;295(19):6299-6311. doi:10.1074/jbc.RA120.012616

a--Yang, L., Liu, S., Liu, J. et al. COVID-19: immunopathogenesis and Immunotherapeutics. Sig Transduct Target Ther 5, 128 (2020). https://doi.org/10.1038/s41392-020-00243-2

b--Yang G,.(2020).H?S as a potential defense against COVID-19?.American Journal of Physiology-Cell Physiology, 319,2, C244-C249 doi/abs/10.1152/ajpcell.00187.2020

--Zanardo, R. C., Brancaleone, V., Distrutti, E., Fiorucci, S., Cirino, G., & Wallace, J. L. (2006). Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J, 20(12), 2118-2120. doi:10.1096/fj.06-6270fje

--Zaorska, E., Tomasova, L., Koszelewski, D., Ostaszewski, R., & Ufnal, M. (2020). Hydrogen Sulfide in Pharmacotherapy, Beyond the Hydrogen Sulfide-Donors. Biomolecules, 10(2), 323. https://doi.org/10.3390/biom10020323.

--Zhao, H., Qu, J., Li, Q., Cui, M., Wang, J., Zhang, K., . . . Chen, Y. (2018). Taurine supplementation reduces neuroinflammation and protects against white matter injury after intracerebral hemorrhage in rats. Amino Acids, 50(3), 439-451. doi:10.1007/s00726-0172529-8

--Zuhra K, Tomé CS, Masi L, et al. (2019). N-Acetylcysteine Serves as Substrate of 3-Mercaptopyruvate Sulfurtransferase and Stimulates Sulfide Metabolism in Colon Cancer Cells. Cells.;8(8):828. doi:10.3390/cells8080828